This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, H.-J.
Right arrow Articles by Lai, C.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, H.-J.
Right arrow Articles by Lai, C.-L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2005, p. 1594-1599, Vol. 43, No. 4
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.4.1594-1599.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Determinants for the Occurrence of Acute Exacerbation of Hepatitis B Virus Infection in Chinese Patients after HBeAg Seroclearance

He-Jun Yuan,1,2 Man-Fung Yuen,1* Danny Ka-Ho Wong,1 Siu-Man Sum,1 Joke Doutreloigne,3 Erwin Sablon,3 and Ching-Lung Lai1

Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong,1 Department of Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China,2 Innogenetics N.V., Ghent, Belgium3

Received 13 September 2004/ Returned for modification 28 October 2004/ Accepted 16 December 2004

This study was performed to determine the factors for predicting the occurrence of acute exacerbation of hepatitis B virus infection in HBeAg-negative patients. Two hundred and sixteen patients with known times of HBeAg seroclearance were recruited. Liver biochemistry and virologic markers were monitored. Precore and core promoter mutations were determined by a line probe assay. The median age at HBeAg seroclearance was 34.5 years. The median follow-up duration was 26.4 months. Fifty-six (27.9%) patients had acute exacerbations. By Cox regression analysis, male gender, older age, and core promoter mutations at the time of HBeAg seroclearance were independently associated with the occurrence of acute exacerbation after HBeAg seroclearance (P = 0.025, 0.018, and 0.001, respectively). Fourteen (7.0%) patients had HBeAg seroreversion within a median follow-up period of 11.6 months after HBeAg seroclearance. By Cox regression analysis, older age at HBeAg seroclearance was independently associated with the chance of HBeAg seroreversion (P = 0.01). We concluded that male patients with core promoter mutations and delayed HBeAg seroclearance had a higher cumulative chance of acute exacerbation in the HBeAg-negative phase. Patients with delayed HBeAg seroclearance had a higher frequency of HBeAg seroreversion.

* Corresponding author. Mailing address: Department of Medicine, The University of Hong Kong Queen Mary Hospital, Pokfulam Rd., Hong Kong, China. Phone: (852) 28553984. Fax: (852) 28725828. E-mail: mfyuen{at}hkucc.hku.hk.

Journal of Clinical Microbiology, April 2005, p. 1594-1599, Vol. 43, No. 4
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.4.1594-1599.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»